{"id":"W4396597402","doi":"10.51731/cjht.2024.882","title":"Nivolumab and Relatlimab (Opdualag)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Medicine; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002106898,0.0004451202,0.0006494113,0.00180167,0.0003027823,0.001387399,0.0005408901,0.0007362587,0.00969639],"category_scores_gemma":[0.003109882,0.0001682932,0.001234757,0.001527708,0.0002612795,0.0007221568,0.0004211682,0.0007961387,0.001986065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003225974,"about_ca_system_score_gemma":0.00585632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02874182,"about_ca_topic_score_gemma":0.09291962,"domain_scores_codex":[0.9986217,0.0003551509,0.0001517821,0.00009984634,0.0006581116,0.0001134835],"domain_scores_gemma":[0.9986365,0.0003343898,0.0002892496,0.00003881434,0.0006188791,0.00008203058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004176848,0.00006355841,0.0007978898,0.01271432,0.0003911993,0.00008598542,0.0000397611,0.0002813079,0.001102175,0.003299569,0.07221992,0.9085866],"study_design_scores_gemma":[0.0001732322,0.0001998974,0.002021926,0.005711915,0.0004074149,0.0002825705,0.00002903096,0.0001055704,0.0007173843,0.0005232511,0.9898144,0.00001335226],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002387463,0.9520809,0.0007518277,0.00263686,0.0008957086,0.0002773498,0.001777352,0.00008877932,0.03910375],"genre_scores_gemma":[0.04503459,0.9040376,0.004774499,0.005274315,0.0006947554,0.0004789135,0.004101292,0.00005403956,0.03554998],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02874182,"threshold_uncertainty_score":0.05714899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02088372641939441,"score_gpt":0.2905325456342415,"score_spread":0.2696488192148471,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}